Zobrazeno 1 - 10
of 24
pro vyhledávání: '"R T, Bartus"'
Autor:
R T, Bartus
Publikováno v:
Current opinion in drug discoverydevelopment. 2(2)
The blood-brain barrier (BBB) serves as an exquisitely controlled, functional gate to the central nervous system (CNS). It not only protects the brain from agents in the blood that could impair neurological function, but also controls the influx and
Publikováno v:
Neuro-oncology. 1(4)
Accumulating evidence suggests that dexamethasone might decrease permeability of the blood-brain tumor barrier, further limiting the delivery of agents into brain tumors. The bradykinin B2 receptor agonist, Cereport (RMP-7), selectively increases per
Autor:
D F, Emerich, P, Snodgrass, R L, Dean, D, Lafreniere, M, Agostino, T, Wiens, H, Xiong, B, Hasler, J, Marsh, M, Pink, B S, Kim, R T, Bartus
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 296(2)
Delivery of chemotherapeutic agents to solid peripheral tumors is compromised because the impaired microvasculature within and surrounding tumors limits diffusion and convection of agents from the vasculature to the tumor. Using a variety of rat tumo
Autor:
D F, Emerich, R L, Dean, P, Snodgrass, D, Lafreniere, M, Agostino, T, Wiens, H, Xiong, B, Hasler, J, Marsh, M, Pink, B S, Kim, B, Perdomo, R T, Bartus
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 296(2)
Intravenous infusions of the bradykinin agonist Cereport (labradimil, formerly RMP-7) enhance delivery of concomitantly administered hydrophilic chemotherapeutic agents to solid tumors. The enhanced delivery produces greater in vivo efficacy of chemo
Publikováno v:
Pharmaceutical research. 17(10)
The following experiments determined whether intravenous infusions of Cereport enhance delivery of chemotherapeutics and prolong survival in rats with metastatic tumors in the brain.Autoradiography and scintillation were used to examine uptake of the
Publikováno v:
The Journal of comparative neurology. 427(1)
Bradykinin has long been known to exist in the central nervous system and has been hypothesized to mediate specific functions. Despite an increasing understanding of the functions of bradykinin, little is known about the cell types expressing the bra
Autor:
D F, Emerich, S R, Winn, P, Snodgrass, D, LaFreniere, M, Agostino, T, Wiens, H, Xiong, R T, Bartus
Publikováno v:
Pharmaceutical research. 17(7)
Delivery of chemotherapeutics using implantable, biodegradable polymers provides a potentially powerful method of treating brain tumors. The present studies examined the ability of injectable microspheres, formulated to release carboplatin or BCNU fo
Autor:
D F, Emerich, S R, Winn, Y, Hu, J, Marsh, P, Snodgrass, D, LaFreniere, T, Wiens, B P, Hasler, R T, Bartus
Publikováno v:
Pharmaceutical research. 17(7)
Implantation of biodegradable polymers provides a powerful method to deliver high, sustained concentrations of chemotherapeutics to brain tumors. The present studies examined the ability of injectable polymeric microspheres, formulated to release car
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 293(3)
Several experiments studied the effects of i.v. infusions of the bradykinin agonist, Cereport (RMP-7), on permeability of the blood-brain tumor barrier in rat gliomas. First, the ability of Cereport to increase uptake of two poorly blood-brain barrie
Publikováno v:
Alcoholism, clinical and experimental research. 23(11)
This study was planned to determine the feasibility of using a slow release naloxone preparation to treat alcoholism, because compliance with medication is a significant problem in alcoholics.Experiments were performed in alcohol-preferring P rats ma